AN2 Therapeutics, Inc. Common Stock

ANTXNASDAQ • USD
4.42 USD
↘ 0.13 (2.86%)🟢LIVE (AS OF 02:00 PM EST)
🟢Market: OPEN

Shares of AN2 Therapeutics, Inc. Common Stock (ANTX) are trading at $4.42. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, ANTX appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$4.51
High?$4.69
Low?$4.43
Prev. Close?$4.55
Volume?140.1K
Avg. Volume?289.9K
VWAP?$4.55
Rel. Volume?0.48x
Bid / Ask
Bid?$3.89 × 100
Ask?$4.55 × 100
Spread?$0.66
Midpoint?$4.22
Valuation & Ratios
Market Cap?172.6M
Shares Out?37.9M
Float?28.8M
Float %?76.3%
P/E Ratio?N/A
P/B Ratio?2.29
EPS?-$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Employees
21
Market Cap
172.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-03-25
Address
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025
Phone: (650) 331-9090
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
44
Piotroski F-Score?0/9Weak
Altman Z-Score?10.87Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.48%Elevated
Short Interest?2.4M
Days to Cover?9.2
Free Float28.8M
Avg Daily Volume265.8K
Settlement Date2026-10-30
Financial Health
Current Ratio?10.48Strong
Quick Ratio?10.48Strong
Cash Ratio?3.22Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
68
2.29CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-46.2%WEAK▾
ROA?
S&P
3
-42.6%WEAK▾
Cash Flow & Enterprise
FCF?$-30409000
Enterprise Value?$152.4M
Fundamentals ratios updated end of day